Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
GC-3111A by GC Biopharma for Pertussis (Whooping Cough): Likelihood of Approval
GC-3111A is under clinical development by GC Biopharma and currently in Phase II for Pertussis (Whooping Cough). According to GlobalData,...